VJHemOnc is committed to improving our service to you

ASH 2019 | Elderly DLBCL updates

VJHemOnc is committed to improving our service to you

Graham Collins

Graham Collins, MA, MBBS, MRCP, FRCPath, DPhil, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, shares his highlights from the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL. Dr Collins specifically discusses news relating to elderly patients with diffuse large B-cell lymphoma (DLBCL).

Share this video  
Similar topics
Related videos
5:14
NK-cell enhancement: TRAIL variant
Michael O'Dwyer
5:09
A CAR-T round-up with Arnon Nagler
Arnon Nagler
9:25
MGUS diagnosis: a step-by-step approach
Graham Jackson
2:53
COVID-19: changing practice for good?
Justin Kline
2:38
Immune landscape and responses to immune checkpoint blockade in lymphoma
Justin Kline
Anemia, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Lymphoma, Non-Hodgkin Lymphoma
Cyclophosphamide, Doxorubicin, Lenalidomide, Prednisone, Vincristine
ASH 2019
Interview
7th December 2019
More from Graham Collins
A key take-home message from the EBMT-EHA CAR T-Cell Meeting
Ones to watch: lymphoma trials
Cami-T: promising results in classical Hodgkin lymphoma
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals